ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AZN Astrazeneca Plc

12,106.00
-20.00 (-0.16%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.00 -0.16% 12,106.00 12,120.00 12,122.00 12,190.00 12,024.00 12,080.00 999,558 16:35:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.55 187.98B

First-Ever Large-Scale Prospective Study in Hispanic Patients With Elevated Cholesterol Demonstrates Significant Cholesterol Re

24/03/2006 1:00pm

PR Newswire (US)


Astrazeneca (LSE:AZN)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Astrazeneca Charts.
WASHINGTON, March 24 /PRNewswire-FirstCall/ -- New data presented today at the National Hispanic Medical Association (NHMA) annual meeting showed that AstraZeneca's CRESTOR(R) (rosuvastatin calcium) at 10 and 20 mg reduced LDL-C or "bad" cholesterol by 45.2 and 50.0 percent, compared to 35.9 and 42.4 percent with atorvastatin at milligram-equivalent doses in Hispanic patients with elevated cholesterol (p

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart

Your Recent History

Delayed Upgrade Clock